Implementation of AIP Services for Older Adults With AD (NCT07361601) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Implementation of AIP Services for Older Adults With AD
United States285 participantsStarted 2026-07-01
Plain-language summary
This study will longitudinally follow a cohort of older adults to better understand how decisions about aging in place or transitioning to long-term care-and the implementation of those decisions-are influenced by age-related changes (e.g., cognition, health literacy, chronic conditions) and social supports (e.g., caregivers).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Active participant in the 'Decision Making and Implementation of Aging-in-Place/Long Term Care Plans among Older Adults' \[R01AG058777\] study;
. Age 65 years or older (older adult); age 18 years or older (caregiver)
. Speak English; and
. Pass UBACC (University of California, San Diego Brief Assessment of Capacity to Consent) cognitive assessment
. Age 18 years or older;
. Speak English;
. Currently assist enrolled, older adult study participant with activities such as managing their health, and/or household activities (i.e., taking them to the doctor, housekeeping, meal prep, medication reminders); and
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is focused on long-term care planning for Alzheimer's and mild cognitive impairment rather than testing a medication or medical procedure — can you help me understand what 'AIP services' means in this context and whether this kind of planning support could be useful for our situation right now?
2Since this study is not yet recruiting, do you have a sense of when it might open, and are there similar care planning programs or services available to us in the meantime?
3The main thing this trial is measuring is how many participants actually complete long-term care planning — what does that process typically involve, and is now a good time for our family to be thinking about those decisions given where we are in the diagnosis?
4Because this is listed as a Phase NA study focused on a service or program rather than a drug, does that change the kinds of risks or commitments we'd need to think about if we eventually considered participating?
5Would taking part in a study like this affect or delay access to other treatments or support programs that might also be appropriate for someone with mild cognitive impairment or early Alzheimer's?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Rate of participant long term care planning for Alzheimer's Dementia/Memory Loss
Timeframe: Assessed every 6 months, 108 months reported